Psoriasis Arthropathica
1 clinical trials · Condition
◉ Watch Psoriasis Arthropathica
| Record | Firm | Date |
|---|---|---|
| Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis) (NCT03885089) | Pfizer | 2019-10-21 |
Track Psoriasis Arthropathica automatically
Every clearance here is in the API, with alerts when new ones post.